Archon Biosciences Analysis: $20M Raised
What is Archon Biosciences?
Computationally designed biologics for disease treatment
Location
Seattle, United States
Employees
11-50
Founded
2023
Product Features & Capabilities
- Antibody Cage (AbC) therapeutics
- Generative AI protein design platform
- Structural control for biodistribution and engagement
Other Considerations
Co-founded by Nobel Prize winner David Baker; Emerged from stealth mode in 2024; Recognized for pioneering work in computational protein design
